Tenderwize
Zurück zur Suche

Medicines contracts with joining option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2027 · 246 days left·Open·Supplies·Framework
Registrieren zum Speichern
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

42/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

42 / 100

Komplexität

58 / 100

Risikofaktoren

The notice explicitly states that it is not a public contract within the meaning of Directive 2014/24/EU or German proc...

The XML notice states that Lot 2 was cancelled.

No procurement documents available

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 2 lots
  • Duration until Sep 2027
  • Framework supply agreement with accession option for pharmaceutical products.
  • Lot 1 covers medicines containing liraglutide, excluding lifestyle medicines.
Vollständige Zusammenfassung anzeigen

This is a German framework agreement with accession option for pharmaceutical products (CPV 33600000), led by BARMER Beschaffung und Vergabe. The notice explicitly states it is not a public contract under procurement law, although the form uses an open procedure label. Two lots are listed: Liraglutid and Ticagrelor. Submission is electronic via https://beschaffungen.barmer.de/ and the deadline is 2027-05-01 10:00 UTC (12:00 local time in the XML). No contract value is provided in the structured data or XML. The XML also indicates Lot 2 was cancelled.

Risiken

The notice explicitly states that it is not a public contract within the meaning of Directive 2014/24/EU or German proc...

The XML notice states that Lot 2 was cancelled.

No procurement documents available

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Administrative

  • Electronic submission via Portal öffnen is allowed.
  • Submission deadline: 2027-05-01 10:00 UTC (XML shows 12:00 local time).
  • The notice states that procurement documents can be downloaded free of charge from the internet; paper copies are not available.

Auftraggeber

Ort

Wuppertal, DEU

Kennung

992-80322-57

Tätigkeit

Health

Lose (2)

LOT-0001

Liraglutide (excluding lifestyle medicines)

Framework supply lot for medicines containing the active substance(s) named in the lot title. Performance location is Wuppertal, Germany. The lot is part of a framework agreement with accession option. No lot value or lot-specific award criteria are provided.

SuppliesFrameworkEU fundedElectronic submission

Ort

Wuppertal, Germany

Dauer

May 2025 - Sep 2027

Kategorie

Pharmaceutical products

Frist

Deadline May 01, 2027

LOT-0002

Ticagrelor

Framework supply lot for medicines containing the active substance(s) named in the lot title. Performance location is Wuppertal, Germany. The lot is part of a framework agreement with accession option. No lot value or lot-specific award criteria are provided. The XML notice states that Lot 2 was cancelled.

SuppliesFrameworkEU fundedElectronic submission

Ort

Wuppertal, Germany

Dauer

May 2025 - Sep 2027

Kategorie

Pharmaceutical products

Frist

Deadline May 01, 2027

Vergabedetails

Veröffentlichungsdatum
25 Aug 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
556029-2025

Dokumente (1)

Einreichungsportal 1

Ähnliche Ausschreibungen

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30